Chromogranin A and other enteroendocrine markers in inflammatory bowel disease

被引：18
|
作者：
Massironi, Sara [1 ]
Zilli, Alessandra [1 ,2 ]
Cavalcoli, Federica [1 ,2 ]
Conte, Dario [1 ,2 ]
Peracchi, Maddalena [1 ,2 ]
机构：
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Gastroenterol & Endoscopy Unit, Via F Sforza 35, I-20122 Milan, Italy
[2] Univ Milan, Postgrad Sch Gastroenterol, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy
来源：
NEUROPEPTIDES | 2016年 / 58卷
关键词：
Chromogranin A; Enteroendocrine cell; Inflammatory bowel disease; Crohn's disease; Ulcerative colitis; VASOACTIVE-INTESTINAL-PEPTIDE; CHRONIC ULCERATIVE-COLITIS; ATYPICAL CARCINOID-TUMOR; NEUROPEPTIDE-Y NPY; SUBSTANCE-P; CROHNS-DISEASE; ION-TRANSPORT; IMMUNOREACTIVE SOMATOSTATIN; PANCREATIC-POLYPEPTIDE; GASTROINTESTINAL-TRACT;
D O I：
10.1016/j.npep.2016.01.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Changes in the distribution and products of enteroendocrine cells may play a role in immune activation and regulation of gut inflammation. This review aims at critically evaluating the main enteroendocrine markers in inflammatory bowel diseases (IBD). A narrative review was performed by searching inflammatory bowel diseases and enteroendocrine biomarkers in PubMed. Relevant modifications of some enteroendocrine markers, such as Chromogranin A, and their correlation with disease activity have been reported in patients with inflammatory bowel diseases. Even if data about neuroendocrine markers are sometimes contrasting, they may be potentially useful for the diagnosis and clinical management of these patients. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码：127 / 134
页数：8
相关论文
共 50 条
  • [41] Markers of Inflammation in the Breath in Paediatric Inflammatory Bowel Disease
    Huang, Yixi
    Lemberg, Daniel A.
    Day, Andrew S.
    Dixon, Barbara
    Leach, Steven
    Bujanover, Yoram
    Jaffe, Adam
    Thomas, Paul S.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2014, 59 (04): : 505 - 510
  • [42] Prevalence of serological markers in familial inflammatory bowel disease
    Moskovitz, D
    Steinhart, H
    Amre, D
    McLeod, R
    Siminovitch, K
    Cohen, Z
    Greenberg, G
    Seidman, E
    Silverberg, M
    GASTROENTEROLOGY, 2002, 122 (04) : A176 - A176
  • [43] Serum markers of Inflammatory Bowel Disease: A literature review
    Purnamaningsih, Siti Muchayat
    BALI MEDICAL JOURNAL, 2018, 7 (02) : 491 - 498
  • [44] Prediagnostic markers in late onset inflammatory bowel disease
    Karling, P.
    Lundgren, D.
    Widbom, L.
    Hultdin, J.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S186 - S187
  • [45] Clinical Utility of Serological Markers in Inflammatory Bowel Disease
    Mokrowiecka, Anna
    Daniel, Piotr
    Slomka, Marta
    Majak, Pawel
    Malecka-Panas, Ewa
    HEPATO-GASTROENTEROLOGY, 2009, 56 (89) : 162 - 166
  • [46] Genetic markers and pediatric onset inflammatory bowel disease
    Mansukhani, M.
    Schwartz, J.
    Twaddell, W. S.
    Martinez, M.
    Remotti, H.
    LABORATORY INVESTIGATION, 2008, 88 : 129A - 129A
  • [47] Serological markers in inflammatory bowel disease: the pros and cons
    Lerner, A
    Shoenfeld, Y
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2002, 14 (02) : 103 - 105
  • [48] Role of serologic markers in diagnosis of inflammatory bowel disease
    Gasilionis, V
    Paner, GP
    Kahn, SE
    Hammadeh, R
    Holmes, EW
    LABORATORY INVESTIGATION, 2005, 85 : 103A - 103A
  • [49] Biochemical markers and bone densitometry in inflammatory bowel disease
    Cano, DL
    Dominguez, YT
    Laria, LC
    Dana, MS
    Esteban, JMH
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2000, 92 (09) : 598 - 600
  • [50] The role and utility of faecal markers in inflammatory bowel disease
    Lehmann, Frank S.
    Burri, Emanuel
    Beglinger, Christoph
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2015, 8 (01) : 23 - 36
12345